Evidence map›Paper›PMID 40837209›Full record

ArticleJPRAS open2025

Evaluation for national guideline adherence and patient-reported outcomes following breast reduction surgery in a public healthcare setting.

Mia W Linde, Julie Allen, Hans Henrik Nielsen

Abstract read
In one paragraph

Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mia W LindeDepartment of Plastic- and Breast Surgery, Aarhus University Hospital, Palle Juul-Jensens Blvd. 99, Aarhus 8200, Denmark.
Julie AllenDepartment of Plastic- and Breast Surgery, Aarhus University Hospital, Palle Juul-Jensens Blvd. 99, Aarhus 8200, Denmark.
Hans Henrik NielsenDepartment of Plastic- and Breast Surgery, Aarhus University Hospital, Palle Juul-Jensens Blvd. 99, Aarhus 8200, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast hypertrophy can lead to significant physical discomfort and reduced quality of life. In Denmark's public healthcare system, access to reduction mammoplasty is guided by criteria including a minimum resection weight of 400-500 g per breast and relevant physical symptoms. This study evaluates adherence to national guidelines and explores patient-reported outcomes following breast reduction surgery. Methods: We conducted a single center observational cohort study, including 44 women who underwent bilateralt breast reception for hypertrophy in 2023. Patients were classified based on resection weight (> 400 g vs. ≤ 400 g per breast). A questionnaire was distributed postoperatively to assess symptom relief, satisfaction, and perceived outcomes. Results: Of the 44 patients, 52 % met the >400 g resection criterion. Thirty-one patients (70.5 %) completed the questionnaire. The most common preoperative symptoms were neck/shoulder pain (93.5 %) and physical activity limitations. Notably, 22.6 % of patients felt their breasts remained too large post-surgery. Conclusions: Despite only partial adherence to resection weight guidelines, the majority of patients experienced substantial symptom relief and reported high satisfaction. The study also underscores the complexity of aligning surgical outcomes with patient selection. While adherence to national guidelines remains important, a more personalized approach to both preoperative assessment and surgical planning may be key to optimizing outcomes and better meeting individual patient needs.

Identifiers

PMID40837209
PMCPMC12362374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.